CIK 0001857044 · Non-accelerated filer<br>Smaller reporting company
Indaptus Therapeutics, Inc.
Sign in to watch- Ticker
- INDP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 863158720
- Phone
- (646) 427-2727
- Business address
- 3 COLUMBUS CIRCLE, 15TH FLOOR, NEW YORK, NY, 10019
- Former names
- Intec Parent Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-04-10 | MADDALUNA ANTHONY J Director | Returned to the company · Stock Option (right to buy) | −500 | $0.50 | $250 | 0 |
| 2025-04-10 | MADDALUNA ANTHONY J Director | Returned to the company · Stock Option (right to buy) | −250 | $0.50 | $125 | 0 |
| 2025-04-10 | MADDALUNA ANTHONY J Director | Returned to the company · Stock Option (right to buy) | −250 | $0.50 | $125 | 0 |
| 2025-04-10 | Linscott Walt Addison Chief Operating Officer | Returned to the company · Stock Option (right to buy) | −1,750 | $0.06 | $103 | 0 |
| 2025-04-10 | Linscott Walt Addison Chief Operating Officer | Returned to the company · Stock Option (right to buy) | −750 | $0.06 | $44 | 0 |
| 2025-04-10 | Linscott Walt Addison Chief Operating Officer | Returned to the company · Stock Option (right to buy) | −1,250 | $0.06 | $74 | 0 |
| 2025-04-10 | Linscott Walt Addison Chief Operating Officer | Returned to the company · Stock Option (right to buy) | −1,125 | $0.06 | $66 | 0 |
| 2025-04-10 | Linscott Walt Addison Chief Operating Officer | Returned to the company · Stock Option (right to buy) | −2,500 | $0.06 | $148 | 0 |
| 2025-04-10 | Linscott Walt Addison Chief Operating Officer | Returned to the company · Stock Option (right to buy) | −1,125 | $0.06 | $66 | 0 |
| 2025-04-10 | Karah Hila Director | Returned to the company · Stock Option (right to buy) | −500 | $0.39 | $195 | 0 |
| 2025-04-10 | Karah Hila Director | Returned to the company · Stock Option (right to buy) | −250 | $0.39 | $98 | 0 |
| 2025-04-10 | Karah Hila Director | Returned to the company · Stock Option (right to buy) | −281 | $0.39 | $110 | 0 |
| 2025-04-10 | Karah Hila Director | Returned to the company · Stock Option (right to buy) | −250 | $0.39 | $98 | 0 |
| 2025-04-10 | Hayes William B Director | Returned to the company · Stock Option (right to buy) | −500 | $0.50 | $250 | 0 |
| 2025-04-10 | Hayes William B Director | Returned to the company · Stock Option (right to buy) | −250 | $0.50 | $125 | 0 |
| 2025-04-10 | Hayes William B Director | Returned to the company · Stock Option (right to buy) | −250 | $0.50 | $125 | 0 |
| 2024-11-25 | Meckler Jeffrey A CEO and Director | Grant or award | +42,553 | $1.18 | $50K | 202,859 |
| 2024-11-25 | Meckler Jeffrey A CEO and Director | Grant or award · Common Stock Warrants | +42,553 | $1.18 | $50K | 42,553 |
| 2024-10-09 | Newman Michael James CSO and Director | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2024-10-09 | Sassi Nir Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 |
Page 3 of 7 · 127 trades